Skip Navigation

Cardiovascular Research 2007 75(2):315-326; doi:10.1016/j.cardiores.2007.04.031
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Seddon, M.
Right arrow Articles by Casadei, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seddon, M.
Right arrow Articles by Casadei, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2007, European Society of Cardiology

Cardiomyocytes as effectors of nitric oxide signalling

Mike Seddona, Ajay M. Shaha and Barbara Casadeib,*

aDepartment of Cardiology, Cardiovascular Division, King's College London, London, United Kingdom
bDepartment of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom

* Corresponding author. Tel.: +44 1865 220132; fax: +44 1865 768844. barbara.casadei{at}cardiov.ox.ac.uk

Nitric oxide (NO) generated constitutively within the heart has long been known to influence myocardial function; however, the precise nature of these effects has been controversial – at least in part – because of the experimental use of non-isoform-selective inhibitors of NO synthases (NOS) and unwarranted extrapolation from results obtained with NO donors. Recent studies using NOS-selective inhibitors and genetically modified models are beginning to redress the balance. It is well established that agonist-stimulated release of NO from eNOS in the coronary endothelium exerts paracrine effects on cardiomyocytes, predominantly affecting the timing of relaxation as well as myocardial oxygen consumption. A significant recent advance has been the finding that both eNOS and nNOS are constitutively expressed in distinct subcellular locations within cardiomyocytes. The relative autocrine role of these isoforms in the cardiomyocyte remains to be fully clarified but evidence suggests that the autocrine effects of nNOS may include the modulation of basal inotropy and relaxation, β-adrenergic responsiveness, and the force-frequency relationship. Myocardial eNOS, on the other hand, may be involved in mediating the inotropic response to sustained stretch. These effects may change significantly in the diseased heart where the expression, activity and/or coupling of NOS isoforms to downstream effectors may be altered.

In this article, we review the current understanding of this important but complex field, focussing particularly on contractile function and on recent advances in knowledge regarding the autocrine functions of nNOS-derived NO.

KEYWORDS Nitric oxide; Cardiac function; Cardiomyocyte; Calcium; Mice


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Proc R Soc BHome page
F. Garofalo, M. L. Parisella, D. Amelio, B. Tota, and S. Imbrogno
Phospholamban S-nitrosylation modulates Starling response in fish heart
Proc R Soc B, November 22, 2009; 276(1675): 4043 - 4052.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
K. Smith, D. Semple, S. Bhandari, and A.-M. L. Seymour
Cellular basis of uraemic cardiomyopathy: a role for erythropoietin?
Eur J Heart Fail, August 1, 2009; 11(8): 732 - 738.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. F. Ceylan-Isik, K. K. Guo, E. C. Carlson, J. R. Privratsky, S.-J. Liao, L. Cai, A. F. Chen, and J. Ren
Metallothionein Abrogates GTP Cyclohydrolase I Inhibition-Induced Cardiac Contractile and Morphological Defects: Role of Mitochondrial Biogenesis
Hypertension, June 1, 2009; 53(6): 1023 - 1031.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. Caporali and C. Emanueli
Cardiovascular Actions of Neurotrophins
Physiol Rev, January 1, 2009; 89(1): 279 - 308.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. Fukuda, J. O-Uchi, and S. Kurihara
Neuronal NO Synthase-Derived NO: A Novel Relaxing Factor in Myocardium?
Circ. Res., February 1, 2008; 102(2): 148 - 150.
[Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
C. N. White, E. J. Hamilton, A. Garcia, D. Wang, K. K. M. Chia, G. A. Figtree, and H. H. Rasmussen
Opposing effects of coupled and uncoupled NOS activity on the Na+-K+ pump in cardiac myocytes
Am J Physiol Cell Physiol, February 1, 2008; 294(2): C572 - C578.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Lim, L. Venetucci, D. A. Eisner, and B. Casadei
Does nitric oxide modulate cardiac ryanodine receptor function? Implications for excitation-contraction coupling
Cardiovasc Res, January 15, 2008; 77(2): 256 - 264.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Lamas, C. J. Lowenstein, and T. Michel
Nitric oxide signaling comes of age: 20 years and thriving
Cardiovasc Res, July 15, 2007; 75(2): 207 - 209.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.